CRISPR Therapeutics (CRSP) Stock Forecast for 2023 – 2026. Sell or Buy Prediction







Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Getting A Kredittkort Norge Approval Isn’t Difficult

February 8, 2024 Getting A Kredittkort Norge Approval Isn’t Difficult

If you meet the conditions, you can open an account for checking in Norway. However, it will be much easier and more convenient…
How to Understand Social Security: 6 Legal & Financial Tips

January 25, 2024 How to Understand Social Security: 6 Legal & Financial Tips

Understanding social security can seem overwhelming, but it’s an important part of financial planning, particularly for retirement. The following 6 legal and financial…
Finding Energy Plans with Billig Strøm Rates

January 10, 2024 Finding Energy Plans with Billig Strøm Rates

It can be overwhelming to decide on the best plan when in a state where electricity is deregulated. The number of providers is…

CRISPR Therapeutics (CRSP) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: February 27, 2024 (07:46)

Sector: Healthcare

The share price of CRISPR Therapeutics AG (CRSP) now

Latest session on the 27th of February for
CRISPR Therapeutics AG is positive
Trading Volume: 2586628
Open: 87.11 /  High: 89.61 /  Low: 84.66
What analysts predict: $85.04
52-week High/Low: $91.1 / $37.55

50/200 Day Moving Average: $66.69 / $57.62

This figure corresponds to the Average Price over the previous 50/200 days. For CRISPR Therapeutics stocks, the 50-day moving average is the support level today.

For CRISPR Therapeutics stocks, the 200-day moving average is the support level today.

Are you interested in CRISPR Therapeutics AG stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the CRISPR Therapeutics stock price in 2024, 2025, 2026, 2027, 2028. How much will one CRISPR Therapeutics share be worth in 2024 - 2028?

When should I take profit in CRISPR Therapeutics stock? When should I record a loss on CRISPR Therapeutics stock? What are analysts' forecasts for CRISPR Therapeutics stock? What is the future of CRISPR Therapeutics stock? We forecast CRISPR Therapeutics stock performance using neural networks based on historical data on CRISPR Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

CRISPR Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for CRISPR Therapeutics shares. This happens once a day.


Historical and forecast chart of CRISPR Therapeutics stock

The chart below shows the historical price of CRISPR Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the CRISPR Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan and Craig Mellow in 2014 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Feb 29 88.70 87.45 89.75 2.63
Mar 01 87.12 86.45 89.61 3.65
Mar 02 86.03 84.69 87.52 3.35
Mar 03 86.19 85.07 87.97 3.41
Mar 04 86.63 84.39 88.91 5.36
Mar 05 86.35 85.48 87.14 1.94
Mar 06 85.61 84.85 87.26 2.84
Mar 07 86.12 85.13 87.39 2.66
Mar 08 89.18 88.32 90.13 2.05
Mar 09 90.60 89.56 92.47 3.26
Mar 10 91.70 89.50 92.96 3.87
Mar 11 92.18 89.76 94.60 5.40
Mar 12 91.49 90.68 93.49 3.10
Mar 13 93.05 91.50 94.12 2.86
Mar 14 93.67 91.00 94.50 3.85
Mar 15 95.40 93.46 97.42 4.23
Mar 16 94.38 91.66 96.13 4.88
Mar 17 97.38 96.34 98.50 2.24
Mar 18 97.74 96.41 100.17 3.90
Mar 19 97.49 96.41 99.33 3.03
Mar 20 99.26 97.13 101.39 4.39
Mar 21 96.43 94.83 98.46 3.84
Mar 22 97.07 94.59 98.29 3.91
Mar 23 96.64 94.25 97.46 3.41
Mar 24 98.93 97.10 101.42 4.45
Mar 25 102.44 99.53 103.85 4.34
Mar 26 104.04 101.88 107.04 5.06
Mar 27 105.73 103.89 107.33 3.31
Mar 28 103.93 102.35 105.16 2.74
Mar 29 101.43 99.82 103.50 3.68

CRISPR Therapeutics Daily Price Targets


CRISPR Therapeutics Stock Forecast 02-29-2024.

Forecast target price for 02-29-2024: $88.70.
Positive dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 2.560%.
Pessimistic target level: 87.45
Optimistic target level: 89.75

CRISPR Therapeutics Stock Forecast 03-01-2024.

Forecast target price for 03-01-2024: $87.12.
Negative dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 3.526%.
Pessimistic target level: 86.45
Optimistic target level: 89.61

CRISPR Therapeutics Stock Forecast 03-02-2024.

Forecast target price for 03-02-2024: $86.03.
Negative dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 3.237%.
Pessimistic target level: 84.69
Optimistic target level: 87.52

CRISPR Therapeutics Stock Forecast 03-03-2024.

Forecast target price for 03-03-2024: $86.19.
Positive dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 3.299%.
Pessimistic target level: 85.07
Optimistic target level: 87.97

CRISPR Therapeutics Stock Forecast 03-04-2024.

Forecast target price for 03-04-2024: $86.63.
Positive dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 5.083%.
Pessimistic target level: 84.39
Optimistic target level: 88.91

CRISPR Therapeutics Stock Forecast 03-05-2024.

Forecast target price for 03-05-2024: $86.35.
Negative dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 1.906%.
Pessimistic target level: 85.48
Optimistic target level: 87.14

CRSP (CRSP) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Mar. 94.46 89.17 103.83 14.12
Apr. 103.53 98.23 109.99 10.69
May. 110.65 104.99 122.34 14.18
Jun. 117.56 109.84 123.95 11.38
Jul. 116.43 102.08 126.30 19.17
Aug. 111.40 99.28 116.21 14.57
Sep. 127.08 122.41 141.31 13.38
Oct. 123.83 118.68 127.99 7.28
Nov. 128.39 116.06 137.01 15.29
Dec. 124.69 114.11 136.46 16.37

CRISPR Therapeutics forecast for this year


CRISPR Therapeutics Stock Prediction for Mar 2024

An uptrend is forecast for this month with an optimal target price of $94.4595. Pessimistic: $89.17. Optimistic: $103.83


CRISPR Therapeutics Stock Prediction for Apr 2024

An uptrend is forecast for this month with an optimal target price of $103.528. Pessimistic: $98.23. Optimistic: $109.99


CRISPR Therapeutics Stock Prediction for May 2024

An uptrend is forecast for this month with an optimal target price of $110.65. Pessimistic: $104.99. Optimistic: $122.34


CRISPR Therapeutics Stock Prediction for Jun 2024

An uptrend is forecast for this month with an optimal target price of $117.555. Pessimistic: $109.84. Optimistic: $123.95


CRISPR Therapeutics Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $116.426. Pessimistic: $102.08. Optimistic: $126.30


CRISPR Therapeutics Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $111.397. Pessimistic: $99.28. Optimistic: $116.21


CRISPR Therapeutics Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $127.081. Pessimistic: $122.41. Optimistic: $141.31


CRISPR Therapeutics Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $123.828. Pessimistic: $118.68. Optimistic: $127.99


CRISPR Therapeutics Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $128.385. Pessimistic: $116.06. Optimistic: $137.01


CRISPR Therapeutics Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $124.687. Pessimistic: $114.11. Optimistic: $136.46



CRISPR Therapeutics (CRSP) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 116.91 107.74 121.58 11.38
Feb 110.36 101.71 114.60 11.25
Mar 123.25 118.12 133.90 11.78
Apr 128.18 121.21 134.54 9.91
May 122.23 109.13 132.21 17.46
Jun 138.86 125.97 155.30 18.88
Jul 147.97 137.79 165.96 16.98
Aug 139.44 124.05 148.14 16.27
Sep 147.70 130.21 163.06 20.14
Oct 129.03 124.28 138.94 10.55
Nov 120.77 107.44 125.02 14.06
Dec 125.99 120.34 131.23 8.29

CRISPR Therapeutics (CRSP) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 119.34 105.97 130.60 18.86
Feb 122.58 115.52 134.55 14.14
Mar 116.31 104.77 130.26 19.57
Apr 124.49 113.34 132.26 14.31
May 140.63 133.20 146.70 9.20
Jun 121.50 116.25 129.86 10.48
Jul 129.08 113.18 144.57 21.71
Aug 137.97 125.16 154.52 19.00
Sep 141.06 131.58 146.02 9.89
Oct 154.60 144.46 169.19 14.62
Nov 148.91 134.14 165.82 19.11
Dec 164.87 158.54 176.48 10.16

CRISPR Therapeutics (CRSP) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 167.77 149.79 176.09 14.94
Feb 155.42 146.22 162.64 10.09
Mar 180.29 168.47 202.50 16.81
Apr 168.47 149.06 181.94 18.07
May 185.72 167.59 199.09 15.82
Jun 197.60 183.69 212.46 13.54
Jul 213.09 191.61 229.80 16.62
Aug 227.07 216.17 251.78 14.14
Sep 223.08 205.94 249.85 17.57
Oct 244.14 231.64 270.70 14.43
Nov 279.29 256.95 294.93 12.88
Dec 294.04 270.51 323.21 16.30

CRISPR Therapeutics (CRSP) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 339.67 325.54 372.82 12.68
Feb 387.50 348.44 425.32 18.08
Mar 361.46 332.54 383.43 13.27
Apr 336.59 324.74 363.52 10.67
May 323.66 291.04 348.00 16.37
Jun 316.93 301.72 349.39 13.64
Jul 296.14 283.82 321.25 11.65
Aug 301.35 284.00 328.35 13.51
Sep 320.64 291.91 351.42 16.93
Oct 332.44 292.55 348.93 16.16
Nov 344.14 321.57 371.12 13.35
Dec 388.74 345.82 437.88 21.02

CRISPR Therapeutics information and performance

CRISPR Therapeutics Address

BAARERSTRASSE 14, ZUG, CH

Market Capitalization: 6 747 198 000 $

Market capitalization of the CRISPR Therapeutics AG is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CRSP shares in the company outstanding by the market price of one share.

EBITDA: -202 700 992 $

EBITDA of CRISPR Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: -0.214

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.94

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 33533.33
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 23.36

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 14.29

Enterprise Value (EV) /Revenue

EV To EBITDA: -26.08

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 80276000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.